165 related articles for article (PubMed ID: 2122975)
41. Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells.
Kawai Y; Matsumoto Y; Watanabe K; Yamamoto H; Satoh K; Murata M; Handa M; Ikeda Y
Blood; 1996 Mar; 87(6):2314-21. PubMed ID: 8630393
[TBL] [Abstract][Full Text] [Related]
42. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
Fukao H; Yamamoto K; Matsuo O
Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
[TBL] [Abstract][Full Text] [Related]
43. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
[TBL] [Abstract][Full Text] [Related]
44. Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 synthesis by diacylglycerol, phorbol ester, and thrombin.
Grulich-Henn J; Müller-Berghaus G
Blut; 1990 Jul; 61(1):38-44. PubMed ID: 2117475
[TBL] [Abstract][Full Text] [Related]
45. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
46. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
Ramsby ML; Kreutzer DL
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
[TBL] [Abstract][Full Text] [Related]
47. Effects of rosuvastatin on fibrinolytic system of human umbilical vein endothelial cells in vitro.
He F; Zhao J; Guo R; Liang Y
Am J Med Sci; 2014 Oct; 348(4):319-23. PubMed ID: 24694789
[TBL] [Abstract][Full Text] [Related]
48. Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor.
Mawatari M; Okamura K; Matsuda T; Hamanaka R; Mizoguchi H; Higashio K; Kohno K; Kuwano M
Exp Cell Res; 1991 Feb; 192(2):574-80. PubMed ID: 1899074
[TBL] [Abstract][Full Text] [Related]
49. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
50. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
51. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine.
Hanss M; Collen D
J Lab Clin Med; 1987 Jan; 109(1):97-104. PubMed ID: 3098881
[TBL] [Abstract][Full Text] [Related]
52. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
[TBL] [Abstract][Full Text] [Related]
53. Tissue plasminogen activator-induced secretion of type-1 plasminogen activator inhibitor in cultured human fibroblasts.
Reilly TM; Greenplate G; Timmermans PB
Thromb Res; 1989 Sep; 55(5):619-25. PubMed ID: 2510361
[TBL] [Abstract][Full Text] [Related]
54. The mechanism of free radical generation in brain capillary endothelial cells after anoxia and reoxygenation.
Wu S; Nagashima T; Ikeda K; Kondoh T; Yamaguchi M; Tamaki N
Acta Neurochir Suppl; 1997; 70():37-9. PubMed ID: 9416271
[TBL] [Abstract][Full Text] [Related]
55. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.
Falkon L; Garí M; Borrell M; Fontcuberta J
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):33-8. PubMed ID: 1623118
[TBL] [Abstract][Full Text] [Related]
56. Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells.
Zhang W; Wojta J; Binder BR
Arterioscler Thromb; 1994 Jul; 14(7):1040-6. PubMed ID: 8018658
[TBL] [Abstract][Full Text] [Related]
57. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.
Owensby DA; Morton PA; Schwartz AL
J Biol Chem; 1989 Oct; 264(30):18180-7. PubMed ID: 2553701
[TBL] [Abstract][Full Text] [Related]
58. Superoxide production by human umbilical vein endothelial cells in an anoxia-reoxygenation model.
Schinetti ML; Sbarbati R; Scarlattini M
Cardiovasc Res; 1989 Jan; 23(1):76-80. PubMed ID: 2550129
[TBL] [Abstract][Full Text] [Related]
59. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
